NAS:PHAS (USA) Also Trade In: Germany

PhaseBio Pharmaceuticals Inc $ 5.85 -0.15 (-2.5%)

Volume:
512,390
Avg Vol (1m):
687,338
Market Cap $:
168.28 Mil
Enterprise Value $:
98.06 Mil
P/E (TTM):
0.00
P/B:
2.38
Warning! GuruFocus has detected with PHAS. Click here to check it out.
5D 3M YTD 1Y 5Y 10Y All 1Y (-%)

Financial Strength

Current Vs Industry Vs History
Cash-To-Debt 7.08
Equity-to-Asset 0.82
Debt-to-Equity 0.16
Debt-to-EBITDA -0.36
N/A
Altman Z-Score 3.99
DISTRESS
GREY
SAFE

Profitability Rank

Current Vs Industry Vs History
Operating Margin % -1948
Net Margin % -1768.28
ROE % -124.89
ROA % -49.59
ROC (Joel Greenblatt) % -1945.46

Valuation Rank

Current Vs Industry Vs History
PB Ratio 2.38
PS Ratio 83.57
EV-to-EBIT -3.07
N/A
EV-to-EBITDA -3.09
N/A
EV-to-Revenue 52.89
Current Ratio 13.98
Quick Ratio 13.98

Dividend & Buy Back

Current Vs Industry Vs History

Valuation & Return

Current Vs Industry Vs History
Price-to-Tangible-Book 2.38
Price-to-Median-PS-Value 0.85
Earnings Yield (Greenblatt) % -32.57